{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-002806","form_type":"8-K","ticker":"AEYE","cik":"0001362190","company_name":"AUDIOEYE INC","filed_at":"2025-03-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.433349+00:00","generated_at":"2026-05-24T22:09:39.419868+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"AudioEye reports Q4 revenue $9.7M (+24% YoY), guides FY25 revenue $41-42M","bullets":["Q4 revenue $9.7M (record, +24% YoY); adjusted EBITDA $2.3M (+77% YoY); adjusted EPS $0.18.","Full year 2024 revenue $35.2M (+12%); net loss narrowed to $4.3M from $5.9M; adjusted EBITDA $6.7M.","FY2025 guidance: revenue $41-42M (~18% growth at midpoint); adjusted EBITDA $9-10M (41% growth).","Board authorized $12.5M share repurchase through Jan 2027; completed ATM for ~$7M at avg $24.65/sh.","Added Jim Hawkins to board; he previously led Natus Medical from $37M to $530M revenue."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-002806","json":"https://secwatch.observer/filing/0001558370-25-002806.json","markdown":"https://secwatch.observer/filing/0001558370-25-002806.md","text":"https://secwatch.observer/filing/0001558370-25-002806.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1362190/000155837025002806/0001558370-25-002806-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1362190/000155837025002806/aeye-20250312x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T22:09:39.419868+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}